| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Electron transport chain oxphos system in mitochondria 0.646168533564681 3.768097641949298 0.0001644963630353 0.0935436541379853 0.0149449222831976 49 O96000,P00403,P14406,P03886,P00846,P21912,O43676,P22695,O14949,Q9UDW1,P24539,Q9Y6M9,O75964,P12235,P06576,Q7KZN9,O95168,O75306,P36542,P13073,O43678 21 |
| Zinc homeostasis 0.948962792229173 3.5168402422165945 0.0004367165466674 0.229547076912691 0.0149449222831976 2 Q92504 1 |
| Nonalcoholic fatty liver disease 0.6111921100792602 3.435615472692514 0.0005912094529587 0.2974624441012932 0.0149449222831976 48 P21912,O43676,O96000,O14949,Q86Y39,P00403,P14406,Q9UDW1,Q9Y6M9,O95168,O75306 11 |
| Drug induction of bile acid pathway 0.9229502798814602 3.400181930062022 0.000673410314576 0.3311272075953638 0.0149449222831976 2 P08183 1 |
| Vitamin a and carotenoid metabolism 0.8788277905828124 3.198347186297601 0.0013821776573894 0.5620851729798023 0.0236625561228311 2 Q6NUM9 1 |
| Urea cycle and related diseases 0.8709252551860376 3.1616556212846625 0.0015687496946688 0.6083077946741895 0.0240575386678609 2 Q9UJS0 1 |
| Proteoglycan biosynthesis 0.8827404479578498 3.1209573088140954 0.0018026416506431 0.659434638193406 0.0262482211081453 3 Q8TB61,Q8NCH0 2 |
| Metabolism of spingolipids in er and golgi apparatus 0.8922570016474437 3.0702465730416213 0.0021388211417912 0.7214739470948544 0.0282073234537272 4 Q10472,O95470,Q06136 3 |
| Estrogen receptor pathway 0.8589111921666799 3.0108017216805907 0.0026055893594283 0.7893520283967862 0.0317456499505861 3 Q9HCL2 1 |
| Statin inhibition of cholesterol production 0.8776115918464806 3.0035329720204196 0.002668646303805 0.7971546580086575 0.0318636368674321 4 Q14534,P37268 2 |
| Sphingolipid metabolism integrated pathway 0.8710950278642328 2.9275240098502793 0.0034167267891878 0.8703968962413231 0.0339964315524186 9 Q13510,Q06136,Q96G23,P27544,O95470,O15269,Q8N5B7 7 |
| Kennedy pathway from sphingolipids 0.8599366220208383 2.922277655144009 0.0034748162148292 0.874829421525363 0.0340076275451322 4 P35790,O95470 2 |
| Sphingolipid metabolism overview 0.8687920604922812 2.880133556850646 0.0039750674207092 0.907249708387572 0.0370705396314694 8 Q13510,Q06136,Q96G23,P27544,O95470,O15269 6 |
| Eicosanoid synthesis 0.8280234551143985 2.8657409516063703 0.0041603453187746 0.91699937235682 0.0370705396314694 3 P09960 1 |
| Vitamin d metabolism 0.8201167797155158 2.8281865898776393 0.0046812512971761 0.9392670487379 0.0382836578686868 3 P38435 1 |
| Pathogenic escherichia coli infection 0.678473795702115 2.773593664067755 0.005544087811498 0.9638120628595936 0.043550268729794 23 Q13885,P68371,P04350,P07437,Q9BVA1 5 |
| Mitochondrial complex iv assembly 0.8360228625863405 2.761618744931228 0.0057515597419759 0.9680503388478856 0.0445932618955797 9 Q9Y2R0,P00403,P14406,Q7KZN9 4 |
| Cholesterol biosynthesis with skeletal dysplasias 0.8541175956883339 2.7454093584606194 0.0060435459738064 0.973189015896992 0.0462563711072105 6 Q15125,Q16850,Q15392 3 |
| Sphingolipid pathway 0.8132558231486929 2.688025026039472 0.0071876009568678 0.9865192569823744 0.0516987683283147 10 Q13510,Q06136,Q96G23,O95470,O15269,P04062,Q8N5B7 7 |
| Omega3 omega6 fatty acid synthesis 0.8363019603752917 2.663162281998126 0.0077410071753976 0.990336131113819 0.0526875095963455 6 O95864,O15254 2 |
| Triacylglyceride synthesis 0.8029654036243751 2.654694846728635 0.0079380180967014 0.99141643593387 0.0526875095963455 4 O00116,Q96AD5,Q9HCL2 3 |
| Mitochondrial complex i assembly model oxphos system 0.643714803403829 2.6210047049368663 0.008767105201159 0.9947892951151162 0.055680444735021 24 O43676,O96000,Q9Y6M9,O43678,P03886,Q9BUB7,O95168,O75306,Q96CU9 9 |
| Oxidative phosphorylation 0.5942380813146771 2.6035970587988375 0.0092251143016883 0.9960457080666802 0.0570578261736735 30 O96000,Q86Y39,P24539,P06576,Q9Y6M9,P03886,O75964,O95168,O75306,P00846 10 |
| Oxidation by cytochrome p450 0.8074798964115235 2.601906880799308 0.0092707020751194 0.9961528538480512 0.0570578261736735 5 Q16850,O43169 2 |
| Mitochondrial complex iii assembly 0.8067190485744306 2.586674035034624 0.0096907218695647 0.9970132682389192 0.0576610579076745 8 Q9Y276,Q9UDW1,Q6DKK2,O14949 4 |
| Phosphodiesterases in neuronal function 0.7643133624169416 2.558116991948654 0.0105240679677394 0.9981931369272196 0.0604121978532733 3 O43924 1 |
| Endothelin pathways 0.804045383436587 2.512129959150593 0.0120004886298259 0.9992590861876112 0.0660376665462712 6 P00403,P16615 2 |
| Autosomal recessive osteopetrosis pathways 0.7332894303589089 2.4943894154916566 0.0126174035217385 0.9994897012979927 0.06725526698641 2 P51798 1 |
| Vitamin b12 disorders 0.7419383310477907 2.447310060969784 0.0143926963321918 0.999825724588311 0.0740727561234357 3 Q99707 1 |
| Mrna protein and metabolite inducation pathway by cyclosporin a 0.7355072463768113 2.415190936918463 0.015726963025811 0.9999223741804772 0.0795677705627895 3 Q15758,Q14145 2 |
| Ketogenesis and ketolysis 0.7609506260447177 2.378453817304901 0.0173854145557075 0.9999716355634796 0.0857776238822924 5 O43772,P23786 2 |
| Relationship between inflammation cox2 and egfr 0.7441764912970179 2.3691779543540923 0.0178276733675097 0.9999783203145576 0.0872386967246175 4 P31751,P31749 2 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.5993448176492896 2.324129720095161 0.0201185426002805 0.9999946222197034 0.0976485360355081 24 Q14739,Q15800,Q15125,Q9BWD1,P37268,O95864,Q14534,Q16850,O00767,Q15392 10 |
| Sarscov2 b117 variant antagonises innate immune activation 0.6934474810668404 2.290768549109246 0.0219768035655116 0.9999982684072752 0.1034014502388411 2 O94826 1 |
| Ciliopathies 0.6425233699670844 2.2659221774669382 0.0234561484961013 0.9999992985855144 0.1054427851358224 19 Q13432,O43924,Q10713 3 |
| Sphingolipid metabolism in senescence 0.7203079061803704 2.2534701190694086 0.0242295227241371 0.9999995629195269 0.1071483338245175 11 Q13510,Q06136,Q96G23,O15269,P16278,P04062 6 |
| Degradation pathway of sphingolipids including diseases 0.7426672058114687 2.243963162964577 0.0248347715706263 0.9999996982205244 0.1082215958223642 7 P17900,P06280,P16278,O43681 4 |
| Acquired partial lipodystrophy barraquersimons syndrome 0.7305143227127485 2.2290571332921187 0.0258101036051796 0.9999998339488928 0.1116567525528424 5 P49354,P02545,O60725 3 |
| Transcription factors regulate mirnas related to cardiac hypertrophy 0.6994094879167667 2.1452060175543144 0.0319363787018589 0.9999999961573716 0.1304354661396814 4 P31751 1 |
| Mitochondrial long chain fatty acid betaoxidation 0.6725260364149419 2.1337327677676057 0.0328646621503199 0.9999999978328472 0.1316792168036308 14 P23786,P50416,Q16836,O43772,Q9BY49 5 |
| Alzheimers disease 0.4165832716448247 2.1268819388185904 0.0334298938840262 0.999999998471324 0.1330509776584246 88 P21796,Q9BUF5,P45880,Q13885,P68371,Q9NQC3,P04350,P07437,O95197,Q9BVA1 10 |
| Mitochondrial immune response to sarscov2 0.7009049248473194 2.089642366996235 0.0366499377218496 0.9999999997914908 0.1430066197381976 9 Q9H845,Q86UT6,Q9Y276,Q9Y6M9 4 |
| Alzheimers disease and mirna effects 0.4122853822317915 2.08041784007251 0.0374872243296497 0.9999999998759256 0.1444977122125504 89 P21796,Q9BUF5,P45880,Q13885,P68371,Q9NQC3,P04350,P07437,O95197,Q9BVA1 10 |
| Omega9 fatty acid synthesis 0.707498791913751 2.0434283850866115 0.0410100499590426 0.9999999999861008 0.1530187489096779 6 O95864 1 |
| Transcription factor regulation in adipogenesis 0.6437273625288075 2.0299190140113814 0.0423647720098692 0.9999999999940232 0.1552169457682509 2 P04150 1 |
| Copper homeostasis 0.6693986215333898 1.9919041990308552 0.046381570172449 0.999999999999514 0.1638449549878821 4 O75880,P31749 2 |
| Microrna network associated with chronic lymphocytic leukemia 0.6354955548238349 1.9860227903634895 0.0470307933895437 0.9999999999996764 0.1641952260441965 2 Q07820 1 |
| 15q112 copy number variation syndrome 0.6627084433200308 1.9573914550292344 0.0503014623593576 0.9999999999999584 0.1715998458773514 4 Q7L576 1 |
| Parkinubiquitin proteasomal system pathway 0.4825533286439825 1.9518883198034576 0.0509514653160736 0.9999999999999724 0.1728296863278179 35 Q13885,P68371,P04350,P07437,Q9BVA1 5 |
| Familial partial lipodystrophy fpld 0.6734955131925757 1.946814094535415 0.0515570265712468 0.9999999999999812 0.1729712424515913 9 O75844,O60725,P31751,Q96AD5,P49354 5 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.6187690400611525 1.9333447608606549 0.0531937412192116 0.9999999999999932 0.1744871621311501 16 P50402,O75844,O60725,P42167,P55209,P11802,P49354 7 |
| Vitamin d in inflammatory diseases 0.6527290152738014 1.905686550120037 0.0566908853396048 0.9999999999999992 0.1829430191769951 4 Q08209,Q16539 2 |
| Pathways of nucleic acid metabolism and innate immune sensing 0.644600846719428 1.863378427170284 0.0624090429822954 1.0 0.1981819077682466 4 Q9Y3Z3,O00584 2 |
| Circadian rhythm genes 0.4552115829134617 1.83619164660052 0.0663293176859456 1.0 0.2041165085490182 41 P00813,Q03164,P43490,P50416,Q15233,Q9BWF3,Q9NRV9,P23246,P11802,P54802,Q8WXF1 11 |
| Influence of laminopathies on wnt signaling 0.6396995298604458 1.8219624256052784 0.0684606871186641 1.0 0.2077098434339796 11 P50402,O75844,O60725,P49354 4 |
| Nocgmppkg mediated neuroprotection 0.6484577283235126 1.813695220719756 0.0697246612936979 1.0 0.2083447815468221 5 P30536,P07196 2 |
| Glycosaminoglycan degradation 0.648366617005027 1.813224213241876 0.0697972467493541 1.0 0.2083447815468221 5 P06865,P54802,P16278 3 |
| Ppar signaling pathway 0.5660172969498073 1.7831267681497438 0.0745656699286765 1.0 0.2159466206845443 19 Q9UKU0,P23786,P50416,Q15067,O95864,O15254 6 |
| 7oxoc and 7betahc pathways 0.6383824043329354 1.7607318024454497 0.0782838073599123 1.0 0.2236145119323812 9 Q15125 1 |
| Cellular proteostasis 0.6198816886039527 1.7336756292198183 0.0829756530254406 1.0 0.2325655627051082 4 Q9UHV9,O15212 2 |
| Glycerophospholipid biosynthetic pathway 0.6401178848270097 1.7228671581648194 0.0849125505859063 1.0 0.2357804311617956 7 Q9BTU6,Q9HCL2,O00116 3 |
| Allograft rejection 0.6287982709820285 1.7093606113196702 0.087384172346338 1.0 0.2393043618842375 9 P08183,P08670,P04439 3 |
| Fatty acid betaoxidation 0.543074720970466 1.6951876238883907 0.090039833920954 1.0 0.2454510541132857 20 Q9UKU0,P40939,P23786,P50416,Q16836,O43772,Q96AD5 7 |
| S1p receptor signal transduction 0.6327675659086749 1.6844739913009414 0.0920901017777309 1.0 0.248768283987807 7 Q13510,P31751 2 |
| Ccl18 signaling pathway 0.6186874372385189 1.6796722293518844 0.0930211058327843 1.0 0.250151352171947 10 P00403,Q86UE4 2 |
| Pregnane x receptor pathway 0.6127438165064327 1.6275540416136836 0.1036194808336081 1.0 0.2667207622024066 5 P08183 1 |
| Leptininsulin signaling overlap 0.5845837203118212 1.627408914636921 0.1036502794488414 1.0 0.2667207622024066 3 P31749 1 |
| Thermogenesis 0.469865463487602 1.620738892285043 0.1050736488406818 1.0 0.2685885066086646 29 Q9UKU0,Q15418,P23786,P50416,O43772,P51812 6 |
| Joubert syndrome 0.5249926733806646 1.5138977112981389 0.1300517847079878 1.0 0.3137232352642967 19 Q13432,Q10713 2 |
| Alpha 6 beta 4 signaling pathway 0.6001834210443693 1.5128258923319415 0.1303238900260395 1.0 0.3137232352642967 7 Q16539,P42345,P31749 3 |
| Amyotrophic lateral sclerosis als 0.577502693351873 1.5014219239290016 0.1332464668466673 1.0 0.3181925628298415 12 P07197,O96008,Q9BUN8,Q08209,Q16539,P07196 6 |
| Glycosylation and related congenital defects 0.5864667988547271 1.4590303417523718 0.1445567567784138 1.0 0.3374483577526384 8 Q96F25 1 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.591357330221346 1.448113691712596 0.1475852569974003 1.0 0.3415054202614263 6 P07099,Q14145,P09601 3 |
| Genes related to primary cilium development based on crispr 0.5592582230504779 1.4358990328348291 0.1510310737530578 1.0 0.3467905808868288 13 A0AVF1,O95684,Q7Z4L5,Q10713 4 |
| Eicosanoid metabolism via lipooxygenases lox 0.5852462049005936 1.4334343694739593 0.1517337421989268 1.0 0.3470691344550166 7 P09960,O15254 2 |
| Bile acids synthesis and enterohepatic circulation 0.5327625946657792 1.42333856860061 0.1546380314463742 1.0 0.3493573434217356 2 P51114 1 |
| Progeriaassociated lipodystrophy 0.5700045576597785 1.4106729491209051 0.1583410707610268 1.0 0.3493573434217356 10 O75844,O60725 2 |
| Ferroptosis 0.4621666785589005 1.3923399693123633 0.1638194734896663 1.0 0.3569351301946378 25 Q9UKU0,P16435,P37268,P45880,Q9Y277,P09601 6 |
| Vitamin b12 metabolism 0.5801545358894493 1.3892276445571676 0.164763537962453 1.0 0.3576866624130344 6 P34897,Q8WTV0,Q99707 3 |
| Disruption of postsynaptic signaling by cnv 0.5749110660826567 1.3782860302043545 0.1681149945995026 1.0 0.3623866727230444 7 Q7L576,Q13555 2 |
| Monoamine transport 0.5377636571456285 1.3716215733210166 0.1701812743725641 1.0 0.3623866727230444 3 O15127 1 |
| Nephrotic syndrome 0.5376224797874648 1.348410824963801 0.1775262842212244 1.0 0.3681274822048405 14 Q7Z4L5,Q14108,O75844 3 |
| Nodlike receptor nlr signaling pathway 0.5159697069476402 1.3293672366138125 0.1837268415584034 1.0 0.3689141278539149 2 Q96RT1 1 |
| Tnfrelated weak inducer of apoptosis tweak signaling pathway 0.5547996088760123 1.325652008430359 0.1849549907148993 1.0 0.3689141278539149 10 Q13546,P31751,Q16539,P31749 4 |
| Tgfbeta signaling in thyroid cells for epithelialmesenchymal transition 0.5425182292435184 1.3193123484963774 0.1870647112148724 1.0 0.3710220352002619 4 P08670 1 |
| Cell migration and invasion through p75ntr 0.5646702482686654 1.3075631712691036 0.1910215153324785 1.0 0.3761929029871431 6 P31751,P31749 2 |
| Tca cycle nutrient use and invasiveness of ovarian cancer 0.5034573592360773 1.2591790176693485 0.2079656785192059 1.0 0.3975199647376052 2 P27361 1 |
| Metastatic brain tumor 0.5154808959156743 1.2488324512368951 0.2117263620428402 1.0 0.402549802992279 3 P04637,P60953 2 |
| Apoptosis modulation by hsp70 0.5332694319883557 1.2048293163873895 0.2282692000618733 1.0 0.4271997255076438 5 O95831 1 |
| Mammary gland development pathway involution stage 4 of 4 0.5036231884057856 1.1833802235108215 0.2366584915054281 1.0 0.4360651834220389 3 P04637,Q07812 2 |
| Tlr4 signaling and tolerance 0.5159360672087393 1.1751119361776423 0.2399499359037635 1.0 0.4407695745678365 4 Q15629 1 |
| Vitamin d receptor pathway 0.5177725950590306 1.156283117649212 0.2475653714647685 1.0 0.4519771460687058 12 P20020,P08183,Q06520,Q96KA5 4 |
| Extracellular vesiclemediated signaling in recipient cells 0.5206394769865033 1.1371015159982554 0.2554958502661897 1.0 0.4608187994227047 5 P35222,P42345,P31749 3 |
| Steroid biosynthesis 0.4790912084293603 1.1223955812024269 0.261694282445039 1.0 0.4663626466259352 2 P51659 1 |
| Pilocytic astrocytoma 0.4731643068817911 1.0891646508340431 0.2760812841857525 1.0 0.4861961365964237 2 P62993 1 |
| White fat cell differentiation 0.4728350345735898 1.0873195259226112 0.2768956221822178 1.0 0.4861961365964237 2 P04150 1 |
| Development of ureteric collection system 0.4835309617918348 1.072543119693495 0.2834761572794724 1.0 0.4948399587597807 3 P35222,P05556 2 |
| Mecp2 and associated rett syndrome 0.4727375170974672 1.0690261901808162 0.2850578682370348 1.0 0.4961502837828274 17 P35637,P52597,P31943,Q00013 4 |
| Metapathway biotransformation phase i and ii 0.4359560548313487 1.0485267289261202 0.294395994107093 1.0 0.5094330680635785 22 P07099,P21964,Q16850,Q8NCH0 4 |
| Tryptophan metabolism 0.4913412872224076 1.0338042858736065 0.3012276676173075 1.0 0.5169827261494777 13 P51648,Q16836,Q15392 3 |
| Praderwilli and angelman syndrome 0.5065041644940513 1.0237230126767622 0.3059661226272188 1.0 0.5233861753823771 8 Q15154,Q7L576 2 |
| Nad metabolism 0.4853768297412286 1.0094363870376883 0.3127653951070794 1.0 0.530457218406041 4 Q8IXJ6 1 |
| Physiological and pathological hypertrophy of the heart 0.4920896506262223 0.9842745179734934 0.3249805550781621 1.0 0.5465165954413037 5 Q08209,Q16539,P40763,Q9P2K5 4 |
| Cholesterol biosynthesis pathway 0.48175854906554 0.9767925615180784 0.3286718593696989 1.0 0.5511716293362647 13 Q16850,P37268,Q14534 3 |
| Hair follicle development cytodifferentiation part 3 of 3 0.459949224978236 0.9430728508808608 0.3456436412815091 1.0 0.5696541211883961 3 P04150 1 |
| Regulation of apoptosis by parathyroid hormonerelated protein 0.4935646399458072 0.94164854621471 0.3463726063507333 1.0 0.5696541211883961 7 P31749,Q9BXK5,Q07812,Q07820 4 |
| Preimplantation embryo 0.4924018822412585 0.9354310944568835 0.3495661785304729 1.0 0.5717561878977873 7 Q99729,P05023 2 |
| Rala downstream regulated genes 0.4922518958127279 0.9246015571051732 0.3551732027977319 1.0 0.5751547297656799 6 Q96KP1,P11233,Q8IYI6,P60953,P16989 5 |
| Caloric restriction and aging 0.4788508675663377 0.9137914774631868 0.3608264255016771 1.0 0.5806290458881435 5 P43490,P31749 2 |
| Nanomaterial induced apoptosis 0.4865208118186193 0.9040254681550688 0.3659818969564841 1.0 0.5826431799547226 7 O95831,Q9NR28 2 |
| Nuclear receptors metapathway 0.3328634503156007 0.8976852158797446 0.3693533934757447 1.0 0.5864467444282436 54 P08183,Q92504,P27105,P23786,P50416,Q15067,Q9H2J7,Q06520,Q9HCL2,P09601 10 |
| Camkk2 pathway 0.4698221410630591 0.8477645399266571 0.3965691149783654 1.0 0.6230309516896951 10 P09601 1 |
| Rac1pak1p38mmp2 pathway 0.4470899470899375 0.8307190831075145 0.4061323433396799 1.0 0.632014103744754 15 P40763,P35222,P63000,O15111,P27361,Q16539,P04637,Q07812,P31749,P05556,Q16512,P16949,P55210,P62993 14 |
| Nad biosynthetic pathways 0.4611157404580925 0.8200931878264127 0.4121629853639619 1.0 0.635817318507197 5 Q8IXJ6 1 |
| Pi3kaktmtor signaling pathway and therapeutic opportunities 0.4552613910223291 0.7894085871189273 0.4298732385985735 1.0 0.6522896001564457 5 O00459,P42345,P31749 3 |
| Hair follicle development organogenesis part 2 of 3 0.4288537549407181 0.7748250628597179 0.4384430374284513 1.0 0.6544833868757907 3 P35222,P05556 2 |
| Hepatitis c and hepatocellular carcinoma 0.4537392883069807 0.7583450506571795 0.4482444441795143 1.0 0.6610779158805792 10 P31350,P31749 2 |
| Adipogenesis 0.4325824432227706 0.7413034652462392 0.4585094610999254 1.0 0.6628163470162977 15 O75844,P43490,P14174,O00767 4 |
| Hostpathogen interaction of human coronaviruses apoptosis 0.4570253540689637 0.7412675355238816 0.4585312417382428 1.0 0.6628163470162977 6 Q16539,Q07812,P31749 3 |
| Pparalpha pathway 0.4491042667916455 0.722635566782061 0.4699038109973643 1.0 0.6751731409476005 9 P23786 1 |
| Spinal cord injury 0.4130644701996413 0.716952062285699 0.4734036762282994 1.0 0.677750586830443 18 Q08209,P08670,P14174,Q9NQC3,P11802 5 |
| Kisspeptinkisspeptin receptor system in the ovary 0.4388275185328412 0.7041325769861633 0.4813502142544748 1.0 0.6842049474045748 5 P31751 1 |
| Purine metabolism and related disorders 0.4260638757692192 0.7013700064364493 0.4830721350378844 1.0 0.685005919212869 15 P00813 1 |
| Gdnfret signaling axis 0.4140316205533621 0.6963107366698861 0.486234250732644 1.0 0.685005919212869 3 P35222,O94813 2 |
| Mthfr deficiency 0.4470377787794116 0.6959738367019281 0.4864452147655038 1.0 0.685005919212869 7 P21964 1 |
| Cardiac hypertrophic response 0.4394374727775443 0.6902597468457529 0.4900308567251492 1.0 0.6880372197199577 11 P31751,Q08209,Q16539,P31749 4 |
| Resistin as a regulator of inflammation 0.43394244351592 0.6241830366501321 0.5325073859194762 1.0 0.7241615248153241 6 P31751,P31749 2 |
| Constitutive androstane receptor pathway 0.4302788633636829 0.6099661045137504 0.5418842611634105 1.0 0.7273652570475763 7 P08183 1 |
| Hostpathogen interaction of human coronaviruses mapk signaling 0.4297942722396645 0.6075073955475874 0.5435142361598118 1.0 0.7273652570475763 7 P51812,Q15418 2 |
| Ovarian infertility 0.3768723981318131 0.5073151839024062 0.6119336864133447 1.0 0.7789433065858566 3 P11802 1 |
| Proximal tubule transport 0.4011812513533216 0.471308550603499 0.6374204104319865 1.0 0.8079405202290785 9 P08183,P05023 2 |
| Somatroph axis gh and its relationship to dietary restriction and aging 0.3588450611697057 0.4213048684396361 0.6735324756607635 1.0 0.8446655475218666 3 P31749 1 |
| Angiogenesis 0.3541469795226969 0.399669400083982 0.6894000330307639 1.0 0.8556586688552309 3 P31749 1 |
| P53 transcriptional gene network 0.3825177365042624 0.3851080173232656 0.7001573882993304 1.0 0.8583038209747438 11 Q7LG56,Q07812,P11166 3 |
| Pyrimidine metabolism and related diseases 0.3775983040592396 0.355948865661764 0.72187885967012 1.0 0.8777223609430991 7 Q7LG56 1 |
| Neural crest cell migration during development 0.3713227229460561 0.3279871429668138 0.7429213838300799 1.0 0.8840255764554384 7 P31751 1 |
| Neural crest cell migration in cancer 0.3713227229460561 0.3279871429668138 0.7429213838300799 1.0 0.8840255764554384 7 P31751 1 |
| Folate metabolism 0.3650988982796905 0.3266542466537965 0.7439294092788469 1.0 0.8840255764554384 14 P00374,Q8WTV0,Q8NFF5,Q99707 4 |
| Histone modifications 0.3701311630933116 0.3215497339434247 0.7477938293299773 1.0 0.8840255764554384 10 Q03164 1 |
| Serine metabolism 0.3689930681331321 0.3177630112535695 0.7506647102746502 1.0 0.8849851064902371 7 P00374,O43175 2 |
| Eicosanoid metabolism via cyclooxygenases cox 0.3651447763379221 0.3010670379688351 0.763363375473733 1.0 0.8953397547304884 7 O15254 1 |
| Gastric cancer network 2 0.3492884528362146 0.2338728452910276 0.8150836949600075 1.0 0.9357787805598548 13 Q86UE4 1 |
| Methionine metabolism leading to sulfur amino acids and related disorders 0.3253351107534188 0.2292156178098773 0.8187013344423293 1.0 0.9363308365173766 4 Q99707 1 |
| Microglia pathogen phagocytosis pathway 0.3302570863546499 0.2078741231519402 0.8353272545499133 1.0 0.9473353781500132 5 O00459,P63000,O15143,Q8NEB9 4 |
| Ciliary landscape 0.267474913193979 0.1874751688362845 0.8512880909138607 1.0 0.9558773548203706 103 Q9Y4W6,P27105,Q96A65,P08670,Q9BT78,Q9HDC9,Q99567,P07197,O75663,A0AVF1,P16278,Q7L5N1,O60645,Q14566,P07196,O15173,Q9NQH7,Q99627,P10619,O43805,Q96PK6,P06280,P61019,P33991,Q92600 25 |
| Selenium micronutrient network 0.3402565745092359 0.1852838306295603 0.8530064197399647 1.0 0.9558773548203706 11 Q99707,Q8WTV0,Q8NFF5,P30048 4 |
| Orexin receptor pathway 0.3313499359007726 0.1768859792517919 0.8595979518958528 1.0 0.9558773548203706 16 O60313,Q9H4L5,Q13595,P11177,P11166,P31350 6 |
| Small cell lung cancer 0.3355525767628078 0.1767456825786265 0.8597081562053461 1.0 0.9558773548203706 14 P24941,P31751,Q07812,P31749,O00459,P11802 6 |
| Insulin signaling in adipocytes diabetic condition 0.3107102121036127 0.1761972176116105 0.8601390066165173 1.0 0.9558773548203706 4 P31751 1 |
| Insulin signaling in adipocytes normal condition 0.3107102121036127 0.1761972176116105 0.8601390066165173 1.0 0.9558773548203706 4 P31751 1 |
| Endometrial cancer 0.3332582840297411 0.1658442678615943 0.8682795077618684 1.0 0.961712182066485 14 P35222,P25054,P31751,Q07812,P31749,O00459 6 |
| Fragile x syndrome 0.2823102086596469 0.1591839704538571 0.8735239325528497 1.0 0.9638585967903422 40 Q9Y4R8,P50570,P53985,P51648,P50416,Q9NZ01,P31749,Q7L576 8 |
| Burn wound healing 0.3318891945311556 0.1572334033733523 0.8750609036187027 1.0 0.9638585967903422 9 P08670 1 |
| Nucleotide metabolism 0.3272925887160238 0.1460277860256583 0.8838994534644173 1.0 0.9694444158578424 15 P00374,Q7LG56 2 |
| Primary focal segmental glomerulosclerosis fsgs 0.3217152632804482 0.1397665644710566 0.8888444316245188 1.0 0.9694444158578424 17 Q14108 1 |
| Type i collagen synthesis in the context of osteogenesis imperfecta 0.3257177526376434 0.1215525899421428 0.9032533627113932 1.0 0.975121623035627 12 P13674,O75718,Q32P28,O15460,P07237 5 |
| Cannabinoid receptor signaling 0.3015300519360209 0.1108106890230943 0.9117664689421696 1.0 0.9825353464954428 5 Q8NCG7 1 |
| Synaptic signaling pathways associated with autism spectrum disorder 0.3207500108260273 0.1012954319331639 0.91931594233313 1.0 0.98888579742861 12 O00459,P31751,P42345,P31749 4 |
| Il18 signaling pathway 0.2589438828011409 0.062733481542448 0.9499787354769604 1.0 1.0 52 P40939,Q8TCT8,P50416,Q16836,Q9HC07,P09601,Q9NZJ7,Q9UMR5,Q13011 9 |
| Apoptosis modulation and signaling 0.3088669254277397 0.0618041090587766 0.9507188311899656 1.0 1.0 15 Q13546,Q9NR28,O95831,Q9Y3E5 4 |
| Angiopoietinlike protein 8 regulatory pathway 0.2788716495735424 0.0593101093985252 0.9527051091556912 1.0 1.0 32 Q15642,P31749,O14654,Q15418,O75955,P13807,P31751,Q16539,P42345,O00767,P11166,O00459,P51812 13 |
| T cell receptor and costimulatory signaling 0.2727997989803207 0.0342932183124676 0.9726433326932732 1.0 1.0 5 Q08209,P31749 2 |
| Envelope proteins and their potential roles in edmd physiopathology 0.2973652201583724 0.0171974516005579 0.9862790952177134 1.0 1.0 16 P42167,Q14739 2 |
| Mammary gland development pathway pregnancy and lactation stage 3 of 4 0.2756346851302317 0.0122983267289362 0.9901876023321908 1.0 1.0 6 P61201,P18031,P06753,P04150,O15111 5 |
| 22q112 copy number variation syndrome 0.2753765027558423 0.0097809724145647 0.9921960375518056 1.0 1.0 28 Q9NQC3 1 |
| Pi3kaktmtor vitd3 signaling 0.2613243058716185 0.0097748363746262 0.9922009331693028 1.0 1.0 5 P31749 1 |
| Mechanoregulation and pathology of yaptaz via hippo and nonhippo mechanisms 0.276055408970984 0.0015579820847614 0.9987569106514548 1.0 1.0 7 P27348,P35221,Q13043,P35222,Q16512,P05556 6 |
| Ethanol effects on histone modifications 0.2909396149241642 0.0013278496233292 0.998940529597818 1.0 1.0 11 P00374 1 |
|
|
